Irvine School of Medicine's Revolutionary iPad Program

UC Irvine School of Medicine's Revolutionary iPad Program to Utilize E-Textbooks from Elsevier.

First-year Med Students Will Access Four Key Titles, Including Netter: Atlas of Human Anatomy, From Their UCI-furnished iPads

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, announced today it will provide four key electronic textbook titles for UC Irvine School of Medicine's new program that gives Apple iPads to its first-year medical students.

Elsevier will provide UCI's incoming medical students with access to Netter: Atlas of Human Anatomy, Gartner: Color Textbook of Histology, Costanzo Physiology and Nussbaum: Thompson & Thompson Genetics in Medicine - all through their new iPads.

"We believe a digitally based curriculum is the future of medical education," said Dr. Ralph V. Clayman, dean of the UCI School of Medicine. "Our commitment to provide these students with the best technology platform and content available is shared by Elsevier, which has responded quickly and positively to our request for high-quality e-textbooks accessible through the iPad."

UCI School of Medicine students and faculty will use their iPads to access Student Consult, (www.studentconsult.com/) Elsevier's online portal where students can access full textbooks plus additional interactive content. Student Consult is where UCI med students will find the four e-textbooks selected for the first term courses. Elsevier will work closely with UCI to monitor the use of the content and the iPads.

"UCI is setting the bar high for how medical schools students and professors should be interacting with medical textbooks," said Randy Charles, Managing Director for Elsevier's Global Clinical Reference Group. "We fully support UCI's progressive move and are working hard to make more of our respected medical content available through mobile devices like the iPad and iPhone."

UCI anticipates it will add further Elsevier texts as the school year progresses.

About Elsevier - Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider, which is owned jointly by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).